The Relationship between C-Reactive Protein (CRP) Levels and HbA1c Levels in Type II Diabetes Mellitus Patients
Article Sidebar
Main Article Content
Abstract
Background: Diabetes mellitus (DM) is a group of metabolic diseases characterized by hyperglycemia due to abnormalities in insulin secretion, insulin action, or both. Type II diabetes mellitus is caused by the pancreas gland being unable to meet the body's insulin needs. The HbA1c test reflects the average blood glucose level for 2-3 months or about 120 days before the test. C-reactive protein (CRP) is an inflammatory biomarker that is often used to assess the level of systemic inflammation. Elevated CRP levels have been associated with insulin resistance, endothelial dysfunction, and the development of atherosclerosis, all of which contribute to complications in diabetic patients. Therefore, further research is needed to evaluate the correlation between HbA1c and CRP levels, to better understand the relationship between glycemic control and systemic inflammation. Objective: This study aims to determine the relationship between C-reactive protein (CRP) levels and HbA1c levels in patients with Type II Diabetes Mellitus. Materials and Methods: This study used purposive sampling technique and analytic survey with cross-sectional approach. Results: Data analysis using the Chi-Square test obtained a p-value of 0.536, where if Sig> 0.05 then it shows there is no significant relationship. So, there is no relationship between C-reactive protein (CRP) levels and HbA1c levels in Type II Diabetes Mellitus patients.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
JoIMedLabS uses license under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-SA 4.0).
The licensing description below is copied from the Creative Commons website:
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
References
Artaya. (2018). Uji chi square dikotomi. December, 1–5. https://doi.org/10.13140/RG.2.2.16332.87682
Bastian, B., Sari, I., & Pratama, F. P. (2022). Analysis of C-Reactive Protein (CRP) Levels in Venous and Capillary Blood Samples with Immunoturbidimetric Methods. Medicra (Journal of Medical Laboratory Science/Technology), 5(1), 1–5. https://doi.org/10.21070/medicra.v5i1.1622
Gunawan, S., & Rahmawati, R. (2021). Hubungan Usia, Jenis Kelamin dan Hipertensi dengan Kejadian Diabetes Mellitus Tipe 2 di Puskesmas Tugu Kecamatan Cimanggis Kota Depok Tahun 2019. ARKESMAS (Arsip Kesehatan Masyarakat), 6(1), 15–22. https://doi.org/10.22236/arkesmas.v6i1.5829
Kalma, K. (2018). Studi Kadar C-Reactive Protein (Crp) Pada Penderita Diabetes Melitus Tipe 2. Jurnal Media Analis Kesehatan, 1(1). https://doi.org/10.32382/mak.v1i1.222
Kemenkes RI. (2015). Permenkes No. 67 Tahun 2015 Tentang Penyelenggaraan Pelayanan Kesehatan Lanjut Usia Di Pusat Kesehatan Masyarakat. Kementerian Kesehatan Indonesia, 16, 89.
Khairinisa, G., Alamanda, C., Herawati, I., & Ali, C. (2022). Hubungan HbA1c dengan C-Reactive Protein Pada Pasien Pende